Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Sanofi SA Add to portfolio

STX:SAN, Oct 23, 08:39 UTC

Latest STX:SAN News

Filter your feed

Apply Filter

Today


News

Sanofi uses the BRI as a springboard into the Chinese primary healthcare market - ChinaKnowledge

SAN

China Knowledge is in the business of providing business solutions and products on China. Within the Group it has financial terminal, publishing, newswires, research, multimedia production and a wide range of consulting services offer to foreign businesses seeking opportunities in China. The company hopes to expand the project to include 14 cities in 12 provinces next year and eventually cover 94% of the area along the BRI by 2020. Sanofi aims to improve China’s primary healthcare through this project to benefit chronic patients and the Chinese people in general and at the same time, building its presence in the country.

Read Full Details

Story Sources

chinaknowledge.com
Topics:
  • Business
  • Health
  • Financial
  • Science
News

Mexico's next president vows security for banks in Santander meeting

SAN

Mexico's next president vows security for banks in Santander meeting. MEXICO CITY, Oct 22 (Reuters) - Mexican President-elect Andres Manuel Lopez Obrador on Monday told the chair of Banco Santander, Spain's biggest bank, that his government will create a safe environment for banks, aimed at encouraging foreign investment. "The domestic banks, the foreign banks, will have security during our government, because we need the investment," he said in a video posted to Twitter, in which he stands next to Santander Executive Chair Ana Botin. Santander, whose local unit is listed on Mexico's stock exchange, committed to invest 15 billion pesos ($773 million) in Mexico between 2017 and 2019, making it among the group's largest investments worldwide.

Read Full Details

Topics:
  • Business
  • Financial
  • Science
News

Sanofi (SNY) is Rich Dividend Yielding stock with rate of 4.17% – Stocks Gallery

SAN

EPS growth is noticed at -12.20% for this year and anticipated 7.74% growth for next year. If we look at the past company’s performance moves, then it recent movement are telling different stories about price movement in different time period. The stock has actually grown in the past week, as the company has gathered a 3.92% return in the past 5 trading days. This trend is based on movement of 50 SMA and stock price is rising off the 50 SMA. If we checked progress of the long term moving average 200 SMA, then we noticed uptrend created which can be described as recent trading price is above the 200 SMA level. Dividend Yield: 4.17% – Volume: 1.65 million, Floating Shares: 2.24 billion – Average Volume: 1.63 million – Outstanding Shares: 2.51 billion. Some investors are searching for a very profitable stock with high dividend yield.

Read Full Details

Story Sources

stocksgallery.com
Topics:
  • Business
  • Financial

Yesterday


News

Sanofi SA (NYSE:SNY) is Hamlin Capital Management LLC’s 9th Largest Position – Fairfield Current

SAN

Hamlin Capital Management LLC decreased its position in Sanofi SA (NYSE:SNY) by 3.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. Squar Milner Financial Services LLC acquired a new position in Sanofi during the 2nd quarter valued at about $169,000. Finally, Bank of America upgraded shares of Sanofi from a “neutral” rating to a “buy” rating and set a $55.00 target price on the stock in a report on Monday, September 10th. In other news, major shareholder Sanofi sold 104,552 shares of Sanofi stock in a transaction on Thursday, September 6th.

Read Full Details

Story Sources

fairfieldcurrent.com
Topics:
  • Business
  • Financial
News

Less Risky stock is less profitable: Sanofi (SNY) – Investor News Place

SAN

Day traders need to be able to get in and out of a stock quickly and with ease, so they will want to trade stocks with high daily volume – typically 1 million shares at absolute minimum. Many value investors look for stocks that are at or near their 52 week low, but this metric alone does not indicate whether a stock is under-valued. For example, a stock may near its 52 week low in a price correction after earnings expectations for future quarters were revised. Sanofi stock waking on thin line between bulls and bears tracks and with several factors it’s pulling towards optimistic side to some extend but some take to pessimistic side. So, volatility evaluation is supposed to give some wisdom of how far the stock will fall if the market takes a dive and how high the stock will rise if the bull starts to climb. For this relative risk measurement, SNY has beta value of 0.73. Sanofi (SNY) stock price traded at a gap of 1.22% from an average price of last twenty days and stands at a distance of 2.97% away from it’s an average price of recent fifty days.

Read Full Details

Topics:
  • Business
  • Financial
News

2 Stocks Take Center Stage: Sanofi (SNY), Francesca’s Holdings Corporation (FRAN)

SAN

2 Stocks Take Center Stage: Sanofi (SNY), Francesca’s Holdings Corporation (FRAN). According to 4 stock analysts, Sanofi, is being kept at an average Outperform, rating, with at least 0.1% of shares outstanding that are currently legally short sold. With these types of results to display analysts, are more optimistic than before, leading 2 of analysts who cover Sanofi (NYSE:SNY) advice their clients to include it in their buy candidate list. However, at the Wall Street, the shares for the company has been tagged a $48.67 price target, indicating that the shares will rally 9.2% from its current levels. The recent close goes a long way in suggesting that the stock price is being underpriced by a 42.86% compared to the most bullish target.Francesca’s Holdings Corporation (FRAN) Returns -61.7% This Year.

Read Full Details

Story Sources

postanalyst.com
Topics:
  • Business
  • Financial
News

Global Cancer Vaccine Market 2018 Key Players: GlaxoSmithkline Plc, Sanpower Group, Astrazeneca Plc. (Medimmune, Pfizer ., Sanofi Pasteur, LLC.) Air Liquide.

GSK SAN +3 more GSK SAN PFE GSK AI

Marketresearch.Biz adds International Cancer Vaccine Market Magnitude, Position and Prediction 2018-2027 new report to its research database. New traders in the Cancer Vaccine market are facing strong contention from traditional global traders as they strive with technological revolutions, dependability and standard of Cancer Vaccine product affairs. The report will be liable to project about the current Cancer Vaccine market evolutions and the magnitude of rivalry, opportunity cost and more. Cancer Vaccine in its database, which furnishes a skillful and deep study of crucial business trends and upcoming Cancer Vaccine market enhancement anticipations, key drivers and moderation, accounts of massive Cancer Vaccine market competitors, categorization and foretell.

Read Full Details

Story Sources

dailyhover.com
Topics:
  • Business
  • Financial
News

Stocks Alert: Sanofi (NYSE:SNY), Cummins Inc. (NYSE:CMI)

SAN CMI

Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi (NYSE) reported its last quarterly earnings on 6/29/2018 where the firm reported its Actual EPS of $0.74/share against the analyst consensus estimate of $0.72/share. The 23 analysts offering 12-month price forecasts for Sanofi SA have a median target of 47.81, with a high estimate of 55.12 and a low estimate of 37.57.

Read Full Details

Story Sources

newburghpress.com
Topics:
  • Business
  • Financial
News

Sanofi SA (SNY) Shares Sold by Bank of New York Mellon Corp – XNewsPress

SAN

Bank of New York Mellon Corp lessened its stake in shares of Sanofi SA (NYSE:SNY) by 11.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The stock has a market capitalization of $111.79 billion, a P/E ratio of 14.24, a P/E/G ratio of 2.44 and a beta of 0.82. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.72 by $0.02. In other news, major shareholder Sanofi sold 104,552 shares of the company’s stock in a transaction that occurred on Thursday, September 6th.

Read Full Details

Story Sources

xnewspress.com
Topics:
  • Business
  • Financial
News

SA health innovators have four days left to enter Sanofi South Africa Challenge – Ventureburn

SAN

SA health innovators have four days left to enter Sanofi South Africa ChallengeBy Staff Reporter on 22 October, 2018. The challenge — held in partnership with the National Department of Health — is focused on innovation that will optimise adherence to the treatment of tuberculosis (TB). Startups will need to present a multi-device and multi-channel solution that will help SA healthcare professionals optimise TB treatment by:. Selected startups stand to receive an opportunity to exhibit their solutions to interested global investors and stakeholders at tech conference AfricArena on 15 and 16 November in Cape Town.

Read Full Details

Story Sources

ventureburn.com
Topics:
  • Business
  • Health
  • Financial
  • Science